GCIM
MDT icon

Gunn & Company Investment Management’s Medtronic MDT Stock Holding History

Gunn & Company Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,140
Closed -$877K – 110
2024
Q2 		$877K Buy
+11,140
New +$913K 0.05% 69
2024
Q1 		– Sell
-14,832
Closed -$1.22M – 104
2023
Q4 		$1.22M Sell
14,832
-11,386
-43% -$868K 0.08% 52
2023
Q3 		$2.05M Buy
+26,218
New +$2.19M 1.81% 26

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gunn & Company Investment Management's MDT Position: Q3 2024 in Review

Gunn & Company Investment Management sold out of Medtronic (MDT) in Q3 2024, closing a stake of 11,140 shares — an estimated $877K sold.

Gunn & Company Investment Management first reported a position in MDT in Q3 2023 and held it in 3 quarters. The position peaked at $2.05M in Q3 2023. 2,065 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Gunn & Company Investment Management reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Gunn & Company Investment Management sold 11,140 Medtronic shares in Q3 2024, an estimated $877K.
  • Gunn & Company Investment Management first reported a position in Medtronic in Q3 2023 and held it in 3 quarters.
  • Gunn & Company Investment Management's Medtronic position peaked at $2.05M in Q3 2023.
  • 2,065 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Gunn & Company Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.